# ILUMYA

NDC: 47335-177
Generic name: tildrakizumab-asmn
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20180806

FDA application: BLA761067

## Active ingredients

- TILDRAKIZUMAB: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"47335-177"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=47335-177
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6a322bb-51b9-4f0e-8642-62a9682ffcde